WC
NGNE icon

Wexford Capital’s Neurogene NGNE Stock Holding History

Wexford Capital’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,050
Closed -$296K – 142
2018
Q1 		$296K Hold
1,050
– – 0.02% 100
2017
Q4 		$247K Hold
1,050
– – 0.02% 113
2017
Q3 		$298K Buy
+1,050
New +$301K 0.03% 129

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UONDDL
University of Notre Dame du Lac South Bend, Indiana $66.8M AUM 43.52% 1-Year Est. Return

Wexford Capital's NGNE Position: Q2 2018 in Review

Wexford Capital sold out of Neurogene (NGNE) in Q2 2018, closing a stake of 1,050 shares — an estimated $296K sold.

Wexford Capital first reported a position in NGNE in Q3 2017 and held it in 3 quarters. The position peaked at $298K in Q3 2017. 44 funds tracked by Wall St. Rank hold NGNE as of Q2 2018.

  • Wexford Capital reported no remaining Neurogene position as of Q2 2018 after selling out during the quarter.
  • Wexford Capital sold 1,050 Neurogene shares in Q2 2018, an estimated $296K.
  • Wexford Capital first reported a position in Neurogene in Q3 2017 and held it in 3 quarters.
  • Wexford Capital's Neurogene position peaked at $298K in Q3 2017.
  • 44 funds tracked by Wall St. Rank held Neurogene as of Q2 2018.

Based on Wexford Capital's 13F filing for Q2 2018, filed 13 Aug 2018.